# Furoscix in Heart Failure Patients With Diuretic Resistance

> **NCT05528588** · PHASE2 · COMPLETED · sponsor: **University of Texas Southwestern Medical Center** · enrollment: 70 (actual)

## Conditions studied

- Heart Failure

## Interventions

- **COMBINATION_PRODUCT:** Furoscix
- **DRUG:** Diuretic Therapy

## Key facts

- **NCT ID:** NCT05528588
- **Lead sponsor:** University of Texas Southwestern Medical Center
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2023-06-02
- **Primary completion:** 2024-04-22
- **Final completion:** 2024-07-01
- **Target enrollment:** 70 (ACTUAL)
- **Last updated:** 2025-07-16

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05528588

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05528588, "Furoscix in Heart Failure Patients With Diuretic Resistance". Retrieved via AI Analytics 2026-06-26 from https://api.ai-analytics.org/clinical/NCT05528588. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*